Adverum Biotechnologies Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
564.00
159,404.00
259,080.00
222,170.00
190,485.00
205,079
Total Accounts Receivable
8.00
-
449.00
886.00
-
-
Other Current Assets
250.00
874.00
1,463.00
2,218.00
3,256.00
3,675
Total Current Assets
822.00
160,278.00
260,992.00
225,274.00
193,741.00
208,754
Net Property, Plant & Equipment
69.00
1,085.00
3,187.00
4,169.00
3,024.00
3,586
Intangible Assets
-
-
-
5,000.00
5,000.00
-
Other Assets
194.00
543.00
140.00
140.00
140.00
156
Total Assets
1,085.00
161,906.00
264,319.00
234,583.00
201,905.00
213,495
Accounts Payable
769.00
951.00
605.00
1,474.00
1,731.00
Other Current Liabilities
393.00
4,520.00
5,969.00
8,422.00
8,943.00
Total Current Liabilities
1,162.00
5,471.00
6,574.00
9,896.00
10,674.00
Long-Term Debt
91.00
-
-
-
-
Deferred Taxes
-
-
-
1,250.00
1,250.00
Other Liabilities
50.00
6,952.00
5,153.00
7,837.00
5,953.00
Total Liabilities
1,303.00
12,423.00
11,727.00
18,983.00
17,877.00
Common Equity (Total)
8,210.00
149,483.00
252,592.00
215,600.00
184,028.00
Total Shareholders' Equity
218.00
149,483.00
252,592.00
215,600.00
184,028.00
Total Equity
218.00
149,483.00
252,592.00
215,600.00
184,028.00
Liabilities & Shareholders' Equity
1,085.00
161,906.00
264,319.00
234,583.00
201,905.00
Preferred Stock (Carrying Value)
7,992.00
-
-
-
-
About Adverum Biotechnologies
View Profile
